Saudi's got a new chill "pill": Global reknown drug company setting up shop in Kingdom
Pfizer Inc, one of the largest pharmaceutical companies in the world, plans to set up new factories in Saudi Arabia and diversify human resources by employing more women in line with the Saudi government policies of giving opportunity to women to take part in the economic development, Hussein Al-Hakim, Director General of Saudi Pfizer, disclosed at a forum in Riyadh recently.
Participating in a “Pioneering, Efficiency, Diversity and Distinctiveness Forum” under the auspices of the Minister of Labor Engineer Adel Fakieh, Al-Hakim stressed tht the rise in the number of people affected with chronic diseases like diabetes, heart illness, blood problems and obesity, among others, necessitates the availability of more healthcare services and pharmaceutical plants in the Kingdom.
He hoped the project would be instrumental in establishing successful partnership with the Kingdom that would benefit the society as a whole.
Furthermore, the Pfizer plant in KAEC, nestled in a 32,234 square meter area, is envisioned to have an output capacity of 18 million packs a year when it starts production in 2015.
The forum was aimed at shedding light on the most important challenges facing the labor market in the Kingdom, which includes developing the national human resources, creating diversity and activating women’s participation in the business sector.
In his speech, Al-Hakim said the company’s patronage and participation in the activities of the Forum falls within the company’s high regard on the value of skills development and training, particularly in an industry that is based on science and knowledge, like medicine.
He also noted that the future of countries depends mainly on the human resources and investment in developing the resources.
Al-Hakim confirmed the keenness of Pfizer since its existence in the Kingdom in the sixties to deepen strategic partnership with the Ministry of Health, Saudi Food and Drug Authority (SFDA), government and private institutions and the medicine industry in the Kingdom.
There was hard work done to develop the healthcare and pharma industry in the Kingdom, he added.
Against this backdrop, Al-Hakim said the company established “Saudi Pfizer Company Limited” factory for the production of the company’s medicine at King Abdullah Economic City.
He said the objective for the establishment of this institutional entity and industrial installation does not stop at just creating job opportunities for qualified Saudi nationals, but exceeds this as it has an important strategic dimension, which is to localize technical knowledge, transfer global expertise and boost the Kingdom’s capabilities in this vital sector for the production of medicines of high quality with international standards.